Your browser doesn't support javascript.
loading
The diversity of inhibitory receptor co-expression patterns of exhausted CD8+ T cells in oropharyngeal carcinoma.
Rao, Yufang; Qiu, Ke; Song, Yao; Mao, Minzi; Feng, Lan; Cheng, Danni; Li, Junhong; Zhang, Ziyan; Zhang, Yuyang; Shao, Xiuli; Pang, Wendu; Wang, Yan; Chen, Xuemei; Jiang, Chuanhuan; Wu, Sisi; Yu, Shuaishuai; Liu, Jun; Wang, Haiyang; Peng, Xingchen; Yang, Lin; Chen, Li; Mu, Xiaosong; Zheng, Yongbo; Xu, Wei; Liu, Geoffrey; Chen, Fei; Yu, Haopeng; Zhao, Yu; Ren, Jianjun.
Affiliation
  • Rao Y; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Qiu K; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Song Y; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Mao M; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Feng L; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Cheng D; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Li J; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang Z; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang Y; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Shao X; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Pang W; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wang Y; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Chen X; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Jiang C; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Wu S; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Yu S; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Liu J; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wang H; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Peng X; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Yang L; MinSheng Ear-Nose-Throat Hospital, Chengdu, Sichuan, China.
  • Chen L; MinSheng Ear-Nose-Throat Hospital, Chengdu, Sichuan, China.
  • Mu X; Langzhong People's Hospital, Nanchong, Sichuan, China.
  • Zheng Y; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Xu W; Department of Biostatistics, Princess Margaret Cancer Centre and Dalla Lana School of Public Health, Toronto, ON, Canada.
  • Liu G; Medical Oncology and Hematology, Princess Margaret Cancer Centre, and Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Chen F; Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Yu H; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhao Y; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Ren J; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
iScience ; 27(5): 109668, 2024 May 17.
Article in En | MEDLINE | ID: mdl-38655196
ABSTRACT
Exhausted CD8+ T cells (Texs) are characterized by the expression of various inhibitory receptors (IRs), whereas the functional attributes of these co-expressed IRs remain limited. Here, we systematically characterized the diversity of IR co-expression patterns in Texs from both human oropharyngeal squamous cell carcinoma (OPSCC) tissues and syngeneic OPSCC model. Nearly 60% of the Texs population co-expressed two or more IRs, and the number of co-expressed IRs was positively associated with superior exhaustion and cytotoxicity phenotypes. In OPSCC patients, programmed cell death-1 (PD-1) blockade significantly enhanced PDCD1-based co-expression with other IR genes, whereas dual blockades of PD-1 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) significantly upregulated CTLA4-based co-expression with other IR genes. Collectively, our findings demonstrate that highly diverse IR co-expression is a leading feature of Texs and represents their functional states, which might provide essential clues for the rational selection of immune checkpoint inhibitors in treating OPSCC.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2024 Type: Article Affiliation country: China